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Background: The foraging choices of honey bees are influenced by many factors, such as floral aroma. The
composition of volatile compounds influences the bioactivity of the aromatic plants and honey produced from
them. In this study, Agastache rugosa was evaluated as part of a project to select the most promising medicinal
plant species for production of bioactive honey.
Methods: Headspace solid-phase microextraction HS-SPME /GC-MS was optimized to identify the volatile bioactive
compounds in the leaves, flower spikes, and for the first time, the flower nectar of Australian grown A. rugosa.
Results: Methyl chavicol (= estragole) was the predominant headspace volatile compound in the flowers with
nectar, flower spikes, and leaves, with a total of 97.16%, 96.74% and 94.35%, respectively. Current results indicate
that HS–SPME/GC–MS could be a useful tool for screening estragole concentration in herbal products.
Conclusion: Recently, estragole was suspected to be carcinogenic and genotoxic, according to the European
Union Committee on Herbal Medicinal Products. Further studies are needed on safe daily intake of Agastache as
herbal tea or honey, as well as for topical uses.
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Agastache rugosa, known as Korean mint, is an ornamen-
tal plant of the Lamiaceae family that is native to Korea,
Japan, and China. It is widely distributed throughout East
Asia and used as a traditional ornamental and medicinal
plant. It is also commercially cultivated for flavouring
agents and as a source of food spice [1]. Several studies
have suggested that A. rugosa exhibits a variety of pharma-
cological and physiological activities, such as antifungal
[2], antibacterial [3], anticancer [4] and antiviral [5] prop-
erties. It is used as a traditional herbal drug for the treat-
ment of intestinal disorders, anorexia, and vomiting [6].
Furthermore, recent studies have shown that A. rugosa ex-
hibits anti-inflammatory and anti-atherogenic properties,
due to high levels of tilianin [1,7].
In fact, the composition of volatile compounds influ-
ences the bioactivity of aromatic herbs and the essential* Correspondence: nitin.mantri@rmit.edu.au
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unless otherwise stated.oils produced from them. The phytotoxic and antimicro-
bial activities of the essential oils from the leaves of A.
rugosa could result from estragole, which is the predom-
inant volatile compound, or estragole in combination
with small quantities of terpenoids [6]. Korean A. rugosa
plants are grouped into five chemo types: Methyl chavi-
col (= estragole), methyl eugenol, methyl eugenol plus
limonene, menthone, and menthone plus pulegone [8]
In addition, the foraging choices of honey bees are influ-
enced by many factors, such as floral aroma. Also, for-
aging bees can distinguish between two volatile oil
chemo types of the same plant species [9]. Agastache
species have been suggested for large-scale cultivation as
a source of nectar for honey bees by different publica-
tions from many nations [7].
Naturally occurring genotoxic and carcinogenic vola-
tile compounds such as estragole are often present in
aromatic plants. Several studies have shown the carcino-
genicity of estragole in experimental animals after a few
reported doses, and after chronic exposure in bacteria. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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estragole, such as 1-hydroxy-estragole; 1-hydroxy-2′,
3′-dihydro- estragole; and 1-acetoxy- estragole have
more hepatocarcinogens than estragole [11]. Indeed
both in vitro and in vivo studies have demonstrated the
formation of hepatic DNA adducts by those metabo-
lites and have defined the major DNA adducts in hep-
atic cells [11,12].
There are considerable differences between volatiles
extracted from fresh living material and the essential oils
obtained from the same plant. Wilson et al. conducted a
study to determine the effectiveness of headspace solid-
phase microextraction (SPME) analysis in combination
with gas chromatography–mass spectrometry to identify
volatile compounds given off by inflorescences and
leaves compared with traditional volatile oil extraction
methods [7]. SPME is a technique first introduced by
Pawliszyn [13]. It is especially valued by the food indus-
try as a less expensive, rapid, and solvent-free technique
for analysing the fractionation of volatile compounds in
different samples [14]. The volatile compounds present
in the essential oils from the leaves and flower spikes of
A. rugosa have been identified by many studies from dif-
ferent areas of the world. However, few studies have exam-
ined the headspace volatile compounds of fresh leaves and
flower spikes using Headspace solid-phase microextrac-
tion [HS-SPME].
To the best of our knowledge, this research study, for
the first time, analysed the volatile compounds present
in the flowers with nectar and compared them to
the compounds present in flower spikes and leaves of
Australian grown A. rugosa. HS-SPME /GC-MS was
used to optimize the suitable conditions for extracting
the volatile compounds and to measure particularly the
amount of estragole and other volatile compounds
present in Australian A. rugosa samples. It was evaluated
as part of a project to select the most promising medi-
cinal plant species to produce bioactive honey from.
Methods
Samples
Agastache rugosa, used in this experiment was verified
and vouchered at the Medicinal Plant Herbarium,
Southern Cross Plant Science (Southern Cross University,
New South Wales, Australia). The voucher number is
PHARM-14-0029. Fresh leaves, flower spikes, and flowers
with nectar of A. rugosa were collected from the Chinese
medicinal garden at the Royal Melbourne Institute of
Technology (RMIT University, Melbourne, Australia) in
the summer of 2012; the temperature range ranged from
22–35°C. To collect flowers with nectar, the inflorescences
were covered with mosquito nets for 24 h before collect-
ing the flowers the next morning (at 9:00 am) in order for
nectar accumulation. To collect flower spikes withoutnectar, the spikes were collected at the budding stage be-
fore nectar secretion began [15]. The samples were kept
on ice during collection and transported to the laboratory,
where 0.15 g of the inflorescence or freshly ground leaf
material was placed into a 4-ml clear, screw-top vial and
sealed with a black polypropylene open-top cap and a
PTFE (Polytetrafluoroethylene)/silicone septum (Agilent
Technologies, Santa Clara, CA).Isolation of volatile compounds
Extraction of the volatiles from the ground leaf material,
flower spikes and flowers with nectar was performed by
HS-SPME. An 85-μm polyacrylate (PA) fibre was fitted
to a manual sampling fibre holder (Supelco, Bellefonte,
PA). The fibre was conditioned according to the manu-
facturer’s instructions before use.Extraction by HS-SPME
The preconditioned PA fibre was inserted into the head-
space of the vial containing the sample, and the vial was
placed in a heating block at 40°C for 50 min. The vola-
tiles were desorbed by placing the fibre into the gas
chromatography (GC) injection port for 5 min. The
equilibrium time profile (solid matrix) was examined
using the method of Da Porto & Decorti, with some
modification [16]. The vials were placed in the heating
block at 40°C instead of 30°C in order to extract all the
compounds that might be present under hot tempera-
tures on summer temperatures in Melbourne. Moreover,
heating at 40°C resulted in an increased amount of vola-
tile compounds on the fibre and a higher number of
resulting peaks compared to heating at 30°C. Figure 1
demonstrates a chromatographic profile for extraction of
the flowers with nectar using PA fibre in HS-SPME after
optimisation.Gas chromatography–mass spectrometry
Identification of the volatile compounds was performed
using an Agilent 5973 MSD fitted with a DB-5 MS (5%-
phenyl)-methylpolysiloxane fused silica column (Agilent)
(30 m x 250 μm i.e., film thickness 0.25 μm). GC–MS
data was obtained under the following conditions: car-
rier gas helium (He 99.99%); flow rate 1.5 ml/min; spilt
ratio 50:1. The initial oven temperature was 40°C for
3 min, after which it was raised from 40°C to 250°C at
6°C/min, where it was held for 5 min. The injection
port, transfer line, and source temperatures were 250°C,
280°C, and 230°C, respectively. The mass scan range was
41–415 m/z as per Adams: Essential Oil Components by
Quadrupole GC/MS. Data acquisition and processing
were performed using MSD ChemStation (E02.00.493)
(Agilent Technologies, Mulgrave, Australia).
Figure 1 Chromatographic profile for extraction of the flower nectar using PA fibre in SPME/GC-MS.
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Qualitative identification was performed using GC–MS
reference libraries (Adams [17], Wiley 7th, and NIST
2.0) using a 80% similarity match cut off value. Concen-
trations of the studied compounds were calculated from
the peak areas in the total ion chromatograms. The rela-
tive abundance was obtained from electronic integrationTable 1 Volatiles compounds extracted from flower spikes, fl
GC-MS
NO. Compound (Adams KI) LRI PtR
1 artemisia triene 930 9.28
2 bicyclogermacrene 1500 23.17
3 bisabolene, b- 1509 23.24
4 bisabolol, a- 1683 26.57
5 caryophyllene < ( E )-> 1419 21.38
6 germacrene D 1480 22.65
7 gurjunene, <gamma> 1477 22.58
8 humulene, <alpha-> 1455 22.13
9 Limonen 1031 12.1
10 methyl chavicol (= estragole) 1195 16.33
11 methyl eugenol 1401 21.01
12 muurolene < gamma-> 1480 22.65
13 octanone, <3-> 986 10.87
14 octen 3 ol <1-> 979 10.67
15 octen-3-yl acetate,< 1-> 1110 14.2
16 hexanol < n-> 871 7.77
17 hexenal < 2E-> 855 7.41
Results are the average of three replicates.
LRI – Linear retention index.
PtR - Predicted retention time.measurements and the results are the average of three
replicates.
Retention indices
Kovats standard retention indices were determined from
the retention times of a series of n-alkane mixture ana-
lysed under identical conditions [17].ower with nectar and leaves of A. rugosa using HS-SPME/
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Volatile composition
In order to determine the amount of estragole and other
volatile compounds presents in the Australian-grown A.
rugosa flowers with nectar, flowers spikes, and leaves,
the samples were subjected to HS–SPME/GC–MS ana-
lysis. Seventeen volatile compounds were identified
where the range of estragole was 94–97% (Table 1). Pre-
viously, many studies indicated that estragole is the most
abundant of the A. rugosa essential oil volatile com-
pounds ranging from 56-94% [8]. In full agreement with
those previous studies, estragole was the predominant
headspace volatile compound in all samples tested by
HS–SPME in this study. Estragole occurred in slightly
different concentrations in the flowers with nectar
(97.16%), flower spikes (96.74%) and leaves (94.35%) as
shown in Figure 2.
Sixteen other trace volatile compounds were detected
in amounts less than 1% in all of the samples analysed
(Figure 3). Six volatile bioactive compounds were
present in all of the samples, but at different concentra-
tions. Some compounds, such as bicyclogermacrene,
were more prevalent in the leaves than in the flower
spikes and flowers with nectar, possibly because the
compound transferred from the leaves to the other parts
of the plant’s inflorescences. However, limonene was
more prevalent in the flowers with nectar than in the
flower spikes and leaves (1.74%, 1.35%, and 0.84%, re-
spectively), and β-caryophyllene was more prevalent in
the flower spikes than in the leaves and flowers with
nectar (1.45%, 1.09%, and 0.84%, respectively). On theFigure 2 Comparison between estragole composition percentage: preother hand, some compounds were present only in the
leaves, flower spikes, or flowers with nectar. For ex-
ample, hexanol < n- > and hexenal < 2E- > were present
in the leaves only. This is not surprising given that these
two compounds are known as the green odour com-
pounds (Table 1).
Comparison of volatile compositions in different locations
The concentrations of estragole compared with the
other volatile compounds differed according to the loca-
tion, particular plant organ, season, and differences
among individuals [18,19]. Our results were similar to
the results of Charles et al. who identified estragole, lim-
onene, and β-caryophyllene as the major volatile com-
pounds in A. rugosa grown in the USA [20]. Ahn and
Yang analysed the essential oils of Korean A. rugosa by
GC–MS and found that estragole was the major volatile
compound, at more than 90%, followed by limonene
(1.4–4.7%) and eugenol (1.4–1.9%) [21]. However, Jun
et al. also analysed the essential oils of Korean A. rugosa
using GC–MS, and they found that limonene was the
major compound, at 47%, and that it contained high
amounts of caryophyllene (17%) and germacrene-D
(14%) [1]. They also found some other minor com-
pounds, such as chavicol, bourbonene, and eugenol, for
a total of 22%.
Generally, the volatile compounds produced from in-
florescences are two to six times more volatile per gram
than those found in the leaves. Our results were similar
to those reported by (Vlietinck & Kubelka 2004) [22]
(1996) for the essential oils found in the leaves andsent in flower spikes, flower nectar and leaves of A. rugosa.
Figure 3 Comparison between other volatiles compounds percentage: present in flower spikes, flower nectar and leaves of A. rugosa.
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that the essential oil in the leaves and flowers was char-
acterised by a high amount of estragole; however, they
reported greater amounts in the leaves than in the
flowers, whereas in the current study, less estragole was
extracted from the leaves by HS–SPME than from the
flower spikes and flower with nectar.
HS–SPME
In this study, HS–SPME conditions were optimized to
extract the volatile bioactive compounds instead of using
traditional essential oil extraction and solvent extraction
methods. Zielińska et al. extracted the volatiles of
Korean A. rugosa leaves using the same HS–SPME/GC–
MS technique, but they used a fibre coated with 50/30-
μm divinylbenzene-carboxen-polydimethylsiloxane for
the extraction process [24]. Despite using different fibres
and different conditions, both studies produced similar
results. In their study, estragole made up 95% of the
total volatile compounds extracted from the leaves, and
ten other volatile compounds were extracted from the
leaves, eight of which were the same as the volatiles ex-
tracted by the current study. These results indicate that
HS–SPME/GC–MS could be a useful tool for screening
estragole concentration in herbal products.
Estragole toxicity
There is only one study using humans, which reported
the amount of 1-hydroxyl-estragole in the urine after
oral administration of estragole to two volunteers. After
oral administration of 100 μg/day for six months, the
urinary extraction of 1-hydroxyl-estragole amounted to
0.2% and 0.4% of the total administered dose, corre-
sponding to the average exposure levels of humans[25]. The profile of metabolism and metabolic activa-
tion has been clearly established by several studies,
showing that covalent binding is dose-dependent. In
particular, a study using mice showed that the carcino-
genicity of estragole is probably minimal in the dose
range of 1–10 mg/kg body weight, which is appro-
ximately 100–1000 times the expected exposure to
estragole from short-term use in adults at dosage rec-
ommendations [22].
Conclusion
To the best of our knowledge, this study is the first to
determine the volatile compounds in the flower nectar
from Australian-cultivated A. rugosa and compare these
with the amounts in the leaves, flower spikes and flowers
with nectar. HS–SPME/ GC-MS conditions were opti-
mized to extract the volatile bioactive compounds in-
stead of using traditional essential oil extraction and
solvent extraction methods. In all of the samples tested,
estragole was present at a high concentration, ranging
94–97%. In 2000, the Committee of Experts on Flavou-
ring Substances (CEFS) evaluated estragole and recom-
mended a limit of 0.05 mg/kg (detection limit). In
addition, in 2004, the European Agency for the Evaluation
of Medicinal Products (EMEA) suggested minimal expos-
ure of estragole to sensitive groups such as children, preg-
nant and breastfeeding women. Although estragole does
not pose a remarkable cancer risk in short-term use by
dosage recommendations, more in vivo and in vitro
studies are needed to determine the risk associated with
long-term exposure to estragole with a wide range of
doses. Further studies are also needed to investigate ex-
ternal and topical uses, as well as daily intake when used
as an herbal tea or honey.
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